Correlagen Announces Launch of Expanded Cardiac Genetic Testing Services.Comprehensive diagnostic testing Diagnostic testing Testing performed to determine if someone is affected with a particular disease. Mentioned in: Von Willebrand Disease offered for all major genetic causes of cardiac disease using 'next generation' sequencing methods WALTHAM, Mass. -- Correlagen today announced the launch of its CardioGeneScan test, the first comprehensive genetic test for the diagnosis of familial cardiac disease. The CardioGeneScan tests for disease-causing variation in all genes known to be associated with familial cardiovascular diseases, including, cardiomyopathy Cardiomyopathy Definition Cardiomyopathy is a chronic disease of the heart muscle (myocardium), in which the muscle is abnormally enlarged, thickened, and/or stiffened. , arrhythmia arrhythmia (ārĭth`mēə), disturbance in the rate or rhythm of the heartbeat. Various arrhythmias can be symptoms of serious heart disorders; however, they are usually of no medical significance except in the presence of , thoracic aortic aneurysm Aortic Aneurysm Definition An aneurysm is an abnormal bulging or swelling of a portion of a blood vessel. The aorta, which can develop these abnormal bulges, is the large blood vessel that carries oxygen-rich blood away from the heart to the rest of the , Noonan Syndrome Noonan syndrome Turner-like syndrome Neonatology A group of specific abnormalities affecting both males and females, both sporadic in appearance but also reflecting a hereditary component, possibly AD Clinical Webbing of neck, pectus excavatum, facial and related diseases, and early-onset coronary artery disease coronary artery disease, condition that results when the coronary arteries are narrowed or occluded, most commonly by atherosclerotic deposits of fibrous and fatty tissue. . Due to its unprecedented breadth of testing, the CardioGeneScan has clinical utility for a wide range of patients with a family history of cardiac disease. Physicians will be able to assess the cardiac genetic make-up of their patients through a single test at a price that is affordable to their patients. More focused disease- or gene-specific testing is also available. "Identifying the genetic cause underlying cardiac disease in an affected family can benefit generations of family members," stated David Margulies David Joseph Margulies (born February 19, 1937) is an American actor. Margulies was born in Brooklyn, New York to Runya (née Zeltzer), a nurse and museum worker, and Harry David Margulies, a lawyer.[1] Margulies graduated from City College of New York. , M.D., Chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Correlagen. "Testing for the presence of familial disease variants can determine risk in young family members and help prevent sudden cardiac death Sudden Cardiac Death Definition Sudden cardiac death (SCD) is an unexpected death due to heart problems, which occurs within one hour from the start of any cardiac-related symptoms. SCD is sometimes called cardiac arrest. through timely intervention. Early diagnosis can, for certain cardiac conditions, allow for early pharmacologic treatment, which can prevent severe disease and costly, painful interventions later. The CardioGeneScan test has a higher sensitivity than any other conventional genetic tests, since it looks for variation in more than one hundred relevant genes." The breadth of the CardioGeneScan is enabled through use of next-generation sequencing technology, which provides greater sequencing capacity at a lower per-gene cost than previous methods. As associations with inherited cardiac disease are demonstrated by researchers and clinicians in the field, Correlagen will add new genes to the CardioGeneScan to keep testing current. In addition, physicians will receive Correlagen's signature 'evergreen' results report, which are revised periodically as new knowledge becomes available about the genetics of cardiac disease that impacts the clinical interpretation of previously identified variants. Such systematic report updating is enabled through Correlagen's unique, evidence-based variant scoring protocols and result reporting processes. Physicians who are interested in this new test may contact Correlagen's client services at testing@correlagen.com or call client services at 781-647-0604. About Correlagen Diagnostics: Correlagen Diagnostics develops and provides genetic testing Genetic Testing Definition A genetic test examines the genetic information contained inside a person's cells, called DNA, to determine if that person has or will develop a certain disease or could pass a disease to his or her offspring. for the diagnosis of disease or the genetic susceptibility for disease. Correlagen's RightReportTM and GeneXplorer systems allow highly consistent test performance and clear, evidence-based result interpretations. As new research findings emerge, Correlagen's 'evergreen' reporting provides updated interpretations and recommendations. Correlagen's is committed to providing clinically important genetic insights to physicians and their patients to accelerate precise diagnosis and help personalize treatment. The company's corporate headquarters are located at 307 Waverly Oaks Street, Suite 101, Waltham, MA 02452, and its telephone number is (781) 647-0604. For more information, please visit www.correlagen.com. |
|
|||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion